» Articles » PMID: 1650454

Regulatory Elements Involved in Constitutive and Phorbol Ester-inducible Expression of the Plasminogen Activator Inhibitor Type 2 Gene Promoter

Overview
Specialty Biochemistry
Date 1991 Jul 25
PMID 1650454
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Gene transcription rates and mRNA levels of plasminogen activator inhibitor type 2 (PAI-2) are markedly induced by the tumor promoting agent phorbol 12-myristate 13-acetate (PMA) in human HT1080 fibrosarcoma cells. To identify promoter elements required for basal-, and phorbol ester-inducible expression, deletion mutants of the PAI-1 promoter fused to the chloramphenicol acetyl transferase (CAT) reporter gene, were transiently expressed in HT1080 cells. Constitutive CAT activity was expressed from constructs containing more than 215 bp of promoter sequence, whereas deletion to position -91 bp abolished CAT gene expression. Treatment of transfected cells with PMA resulted in a three- to ten-fold increase in CAT expression from all constructs except from the construct shortened to position -91. DNAse1 protection analysis of the promoter region between -215 and the transcription initiation site revealed numerous protected regions, including two AP1-like binding sites (AP1a and AP1b) and one CRE-like element. Site-directed mutagenesis of the AP1a site or of the CRE-like site resulted in the loss of basal CAT activity and abolished the PMA effect, whereas mutagenesis of AP1b only partially inhibited basal and PMA-mediated expression. Our results suggest that the PAI-2 promoter contains at least two elements required for basal gene transcription and PMA-mediated induction.

Citing Articles

SERPINB2-its regulation and interplay with aryl hydrocarbon receptor.

Brauze D J Appl Genet. 2021; 62(1):99-105.

PMID: 33387293 DOI: 10.1007/s13353-020-00606-z.


The transcription factor C/EBP-β mediates constitutive and LPS-inducible transcription of murine SerpinB2.

Udofa E, Stringer B, Gade P, Mahony D, Buzza M, Kalvakolanu D PLoS One. 2013; 8(3):e57855.

PMID: 23472114 PMC: 3589482. DOI: 10.1371/journal.pone.0057855.


Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator.

Stringer B, Udofa E, Antalis T J Biol Chem. 2012; 287(13):10579-10589.

PMID: 22334683 PMC: 3322994. DOI: 10.1074/jbc.M111.318758.


Genomic responses from the estrogen-responsive element-dependent signaling pathway mediated by estrogen receptor alpha are required to elicit cellular alterations.

Nott S, Huang Y, Li X, Fluharty B, Qiu X, Welshons W J Biol Chem. 2009; 284(22):15277-88.

PMID: 19321454 PMC: 2685708. DOI: 10.1074/jbc.M900365200.


Gastrin activates paracrine networks leading to induction of PAI-2 via MAZ and ASC-1.

Almeida-Vega S, Catlow K, Kenny S, Dimaline R, Varro A Am J Physiol Gastrointest Liver Physiol. 2008; 296(2):G414-23.

PMID: 19074642 PMC: 2643906. DOI: 10.1152/ajpgi.90340.2008.


References
1.
Graham F, Van Der Eb A . A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973; 52(2):456-67. DOI: 10.1016/0042-6822(73)90341-3. View

2.
Gonda T, Sheiness D, Bishop J . Transcripts from the cellular homologs of retroviral oncogenes: distribution among chicken tissues. Mol Cell Biol. 1982; 2(6):617-24. PMC: 369837. DOI: 10.1128/mcb.2.6.617-624.1982. View

3.
Stephens R, Pollanen J, Tapiovaara H, Leung K, Sim P, Salonen E . Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol. 1989; 108(5):1987-95. PMC: 2115548. DOI: 10.1083/jcb.108.5.1987. View

4.
Cubellis M, Andreasen P, Ragno P, Mayer M, Dano K, Blasi F . Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Proc Natl Acad Sci U S A. 1989; 86(13):4828-32. PMC: 297508. DOI: 10.1073/pnas.86.13.4828. View

5.
Kirchheimer J, Remold H . Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors. Blood. 1989; 74(4):1396-402. View